Searching the Register
The Register includes the following information for each company: company’s name, address, country of origin, contact details, number of employees, company’s creation date and its general field of activity. It also include information about its product portfolio and development stage. Specific information about individual products is not included in the database.
Please note that selecting more than one field finds companies matching all fields selected (AND-relation).
|
|
FIELD AND COUNTRY
|
| |
|
Company Name |
|
| |
|
Field of Activity |
|
| |
|
Country |
|
| COMPANY SECTOR |
| |
(Bio) Pharmaceutical |
|
|
| |
|
Early manufacturing/Research&Discovery stage |
|
| |
|
Development stage |
|
| |
|
Commercialisation/Marketing stage (EU/Non-EU) |
|
| |
Medical Device and Technology |
|
|
| |
|
Development stage |
|
| |
|
Commercialisation/Marketing stage (EU/Non-EU) |
|
| PRODUCT INFORMATION |
| |
Medicinal Products |
|
| |
|
Vaccines |
|
| |
|
Therapeutic medicines |
|
| |
|
Diagnostic and imaging products |
|
| |
|
Combined medicinal products and devices |
|
| |
Product Development Stages |
|
| |
|
Research/Discovery |
|
| |
|
Pharmaceutical development |
|
| |
|
Preclinical |
|
| |
|
Clinical exploratory |
|
| |
|
Clinical confirmatory |
|
| |
|
(Pre)registration (EU/Non-EU) |
|
| |
|
Marketing (EU/Non-EU) |
|
SUBSTANCES |
| |
Chemical entities |
|
|
| |
|
Single entities |
|
| |
|
Combinations of single entities |
|
| |
|
Peptides (chemically synthesised) |
|
| |
Biologically derived proteins and peptides |
|
|
| |
|
Monoclonal antibodies |
|
| |
|
Recombinant proteins |
|
| |
|
Extracted proteins |
|
| |
Nucleic Acids (chemically synthesised/biologically derived) |
|
| |
|
RNA |
|
| |
|
DNA |
|
| |
Polymers (natural and synthetic - excluding peptides, proteins and nucleic acids) |
|
| |
|
Homopolymers |
|
| |
|
Copolymers |
|
| |
Advanced therapy medicinal products |
|
| |
|
Somatic cell therapy products |
|
| |
|
Tissue engineered products |
|
| |
|
Gene therapy products |
|
| |
Radionuclides |
|
|
| |
Allergens |
|
|
| |
Polyclonal immunoglobulins |
|
|
| |
Herbal derived complex substances |
|
|
| |
Animal derived complex substances |
|
|
| |
Other |
|
|
| SPECIFIC CATEGORIES |
| |
|
Biodefense |
|
| |
|
Biosimilars |
|
| |
|
Excipients |
|
| |
|
Foods (functional foods, nutraceuticals) |
|
| |
|
Generics |
|
| |
|
Genetically modified organisms (GMOs) |
|
| |
|
Homeopathics |
|
| |
|
Maximum residue limits (veterinary medicines) |
|
| |
|
Artificial intelligence, big data, software as medical device, digital health/medicines |
|
| |
|
Medicines for tropical diseases |
|
| |
|
MUMS (‘Minor Use/Minor species’)/Limited market (veterinary medicines) |
|
| |
|
Nanotechnology (including e.g. microparticles, liposomes, microbeads) |
|
| |
|
New formulations/delivery methods |
|
| |
|
Orphan medicines |
|
| |
|
OTC (over the counter)/non-prescription/self-medication |
|
| |
|
Paediatric medicines |
|
| |
|
Personalised/targeted products, biomarkers, pharmacogenomics, precision medicines, companion diagnostics |
|
| |
|
Stem cells |
|
| |
|
Transgenic technology |
|
| |
|
Other |
|
| THERAPEUTIC AREA |
| |
|
A Alimentary tract and metabolism |
|
| |
|
B Blood and blood forming organs |
|
| |
|
C Cardiovascular system |
|
| |
|
D Dermatologicals |
|
| |
|
G Genito-urinary system and sex hormones |
|
| |
|
H Systemic hormonal preparations, excluding sex hormones |
|
| |
|
J General anti-infectives for systemic use |
|
| |
|
L Anti-neoplastic and immunomodulating agents |
|
| |
|
M Musculo-skeletal system |
|
| |
|
N Nervous system |
|
| |
|
P Anti-parasitic products, Insecticides, Repellents |
|
| |
|
R Respiratory system |
|
| |
|
S Sensory organs |
|
| |
|
V Various |
|
| |
|
|
|
